M. Luinstra, MSc

Research

Postal address:
A Deusinglaan
1
Groningen
Netherlands
Phone: +31 50 363 3284Fax: +31 50 363 2500
Publications
  1. Learning from Parkinson's patients: Usability of the Cyclops dry powder inhaler

    Luinstra, M., Isufi, V., de Jong, L., Rutgers, A. W. F., Hagedoorn, P., Puttenstein, J., van Laar, T. & Frijlink, H. W., 15-Aug-2019, In : International Journal of Pharmaceutics. 567, p. 118493 5 p., 118493.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Pharmacokinetics and tolerability of inhaled levodopa from a new dry-powder inhaler in patients with Parkinson's disease

    Luinstra, M., Rutgers, W., van Laar, T., Grasmeijer, F., Begeman, A., Isufi, V., Steenhuis, L., Hagedoorn, P., de Boer, A. & Frijlink, H. W., 21-Jun-2019, In : Therapeutic advances in chronic disease. 10, 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. PHARMACOKINETIC EVALUATION AND TOLERABILITY OF INHALED DRY POWDER LEVODOPA IN PARKINSON'S DISEASE PATIENTS

    Luinstra, M., Rutgers, A. W. F., Vroegop, S. J., Begeman, A., Lexmond, A. J., Grasmeijer, F., Hagedoorn, P., de Boer, A. H. & Frijlink, H. W., Apr-2018, In : Journal of aerosol medicine and pulmonary drug delivery. 31, 2, p. A9-A9 1 p.

    Research output: Contribution to journalMeeting AbstractAcademic

  4. Ziekte van Parkinson, levodopagebruik en het risico op melanoom

    Hummels, H., Sebek, L., Rutgers, W., Harms, P., Brinkman, I. & Luinstra, M., 18-Nov-2016, In : Pharmaceutisch Weekblad. 151, 46, p. 32-34 3 p.

    Research output: Contribution to journalArticleAcademic

View all (11) »

View graph of relations

ID: 311955